Trial intelligence / Profile preview

Helicobacter pylori Eradication vs Aspirin Toxicity Trial

2007-003577-74Phase 4Terminated

Sponsor
University of Nottingham
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of clarithromycin, metronidazole and omeprazole in Helicobacter pylori infection and bleeding peptic ulcer, sponsored by University of Nottingham. Primary endpoint: Ulcer bleeding rate in aspirin users. Started Aug 2007; status: terminated.

02

Drugs

clarithromycinmetronidazoleomeprazole
03

Conditions

Helicobacter pylori infectionbleeding peptic ulcer

Beyond the preview

Go deeper on 2007-003577-74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003577-74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call